PL444904A1 - Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych - Google Patents

Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych

Info

Publication number
PL444904A1
PL444904A1 PL444904A PL44490423A PL444904A1 PL 444904 A1 PL444904 A1 PL 444904A1 PL 444904 A PL444904 A PL 444904A PL 44490423 A PL44490423 A PL 44490423A PL 444904 A1 PL444904 A1 PL 444904A1
Authority
PL
Poland
Prior art keywords
derivatives
sulfanylpyridine
conjugated
dimethyl
application
Prior art date
Application number
PL444904A
Other languages
English (en)
Inventor
Małgorzata Strzelecka
Benita WIATRAK
Piotr ŚWIĄTEK
Original Assignee
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu filed Critical Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority to PL444904A priority Critical patent/PL444904A1/pl
Publication of PL444904A1 publication Critical patent/PL444904A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pierwszym przedmiotem zgłoszenia jest nowa pochodna 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, przedstawiona wzorem ogólnym (I). Ponadto, wynalazek obejmuje sposób otrzymywania nowej pochodnej 4 o wzorze ogólnym (I), jej zastosowanie do leczenia chorób nowotworowych oraz do otrzymywania kompozycji leczniczych.
PL444904A 2023-05-15 2023-05-15 Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych PL444904A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL444904A PL444904A1 (pl) 2023-05-15 2023-05-15 Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL444904A PL444904A1 (pl) 2023-05-15 2023-05-15 Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych

Publications (1)

Publication Number Publication Date
PL444904A1 true PL444904A1 (pl) 2024-11-18

Family

ID=93522705

Family Applications (1)

Application Number Title Priority Date Filing Date
PL444904A PL444904A1 (pl) 2023-05-15 2023-05-15 Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych

Country Status (1)

Country Link
PL (1) PL444904A1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096781A1 (en) * 2003-04-25 2004-11-11 Astrazeneca Ab Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
WO2005039569A1 (en) * 2003-10-18 2005-05-06 Bayer Healthcare Ag 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases
US20060100235A1 (en) * 2003-04-11 2006-05-11 Novo Nordisk A/S Pharmaceutical use of substituted 1,2,4-triazoles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100235A1 (en) * 2003-04-11 2006-05-11 Novo Nordisk A/S Pharmaceutical use of substituted 1,2,4-triazoles
WO2004096781A1 (en) * 2003-04-25 2004-11-11 Astrazeneca Ab Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
WO2005039569A1 (en) * 2003-10-18 2005-05-06 Bayer Healthcare Ag 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOHAMMED B. WATHIQ AL-TAMIMI.: "International Journal of Health Sciences, August 2022, 7185-7203", SYNTHESIS, IDENTIFICATION OF SOME NEW 1,2,4-TRIAZOLE DERIVATIVES FROM 6-AMINO-1,3-DIMETHYLURACIL AND EVALUATION OF THEIR MOLECULAR DOCKING, ANTI-OXIDANT AND EXPERIMENTAL *

Similar Documents

Publication Publication Date Title
GEAP202416530A (en) Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof
ZA202405986B (en) Nlrp3 inflammasome inhibitor and uses thereof
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
CL2021001396A1 (es) Derivados de panteteína y usos de los mismos
CR7743A (es) Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf)
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
MX2022015886A (es) Derivados de amidopirimidona.
CR20220478A (es) Derivados de benzodiazepinas como pam de gaba a gamma 1
MX2025007434A (es) Compuesto con anillo fusionado de pirazol, metodo de preparacion y uso del mismo
MX2023006578A (es) Heteroaril-acetilenos, sus composiciones farmacéuticas y sus aplicaciones terapéuticas.
ZA202501471B (en) Preparation and use of quinazolinone derivative as kinase inhibitor
CR20240203A (es) Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2
MX2024000999A (es) Antagonista de molécula pequeña de lpa1.
CO2024010803A2 (es) Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico
MX2025012370A (es) Compuesto de amida, composicion farmaceutica que comprende el compuesto y uso de esta
PL444904A1 (pl) Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych
MX2025010357A (es) Degradador de irak4, y uso del mismo
MX2024008008A (es) Derivado triciclico inhibidor, metodo de preparacion de este y aplicacion de este.
DE602005011267D1 (de) Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen
CR20230218A (es) Nuevos derivados de indazol acetileno
AU2021326530A8 (en) Dosage form compositions comprising an inhibitor of btk and mutants thereof
MX2022008343A (es) Compuestos de esteroides especificos.
GEAP202516802A (en) Protac chimeric compound, preparation method thereof and use thereof
GB1215858A (en) Nitroimidazole derivatives
GEAP202516765A (en) Exatecan-derived adc linker-payloads, pharmaceutical compositions, and uses thereof